United States Bioprocessing Equipment Market to hit US$ 147.55 Billion by 2033 | Top Companies 2025 - Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation (Cytiva)

"The global bioprocessing equipment market size reached US$ 58.14billion with rise of US$63.45billion in 2024 is expected to reach US$ 147.55billion by 2033, growing at a CAGR of 9.9%during the forecast period 2025-2033" As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/bioprocessing-equipment-market?sp

United States: Recent Industry Developments

✅ In September 2025, Sartorius launched an automated single-use bioreactor system for mammalian cell culture. The system improves scalability and reduces contamination risk. Early adoption shows accelerated process development and higher production efficiency.

✅ In August 2025, GE Healthcare Life Sciences invested $80 million in expanding its bioprocessing equipment manufacturing facility in Massachusetts. The expansion focuses on high-capacity filtration and chromatography systems. Initial operations aim to meet rising demand for biologics and gene therapies.

✅ In July 2025, Pall Corporation introduced next-generation perfusion systems for continuous cell culture. The platform enhances yield, reproducibility, and process control. Pilot implementations demonstrate reduced manufacturing costs and improved batch consistency.

✅ In June 2025, Eppendorf deployed automated upstream and downstream equipment solutions for contract manufacturing organizations. The system integrates AI monitoring and real-time analytics. Early use shows better process predictability and reduced downtime.

Japan: Recent Industry Developments

✅ In September 2025, Hitachi Chemical launched high-throughput bioreactors for cell and gene therapy production. The equipment improves process efficiency and scalability. Early adoption indicates faster development timelines and higher yields.

✅ In August 2025, Takeda Pharmaceutical invested ¥12 billion to upgrade bioprocessing equipment in its production facilities. The initiative focuses on single-use technologies and advanced monitoring systems. Initial operations enhance production flexibility and quality assurance.

✅ In July 2025, Kobelco introduced integrated purification and filtration systems for monoclonal antibody production. The systems optimize downstream processing and reduce contamination risk. Pilot projects show improved efficiency and regulatory compliance.

✅ In June 2025, Ajinomoto Bio-Pharma Services expanded its bioprocessing equipment portfolio with automated chromatography and cell culture platforms. The initiative supports scalable manufacturing for biologics. Early deployments highlight better reproducibility and operational efficiency.

Bioprocessing Equipment Market: Drivers

The bioprocessing equipment market is experiencing robust growth as the demand for biologics, vaccines, and advanced therapeutics continues to rise globally. These equipment systems, including bioreactors, fermenters, filtration units, and chromatography systems, are essential for the cultivation, separation, and purification of biological products. Rising adoption of personalized medicine, cell and gene therapies, and monoclonal antibody production is driving the need for high-efficiency, scalable bioprocessing solutions. Continuous innovations in automation, single-use technologies, and process analytical tools are enhancing productivity, reproducibility, and operational efficiency. Growing partnerships between contract development and manufacturing organizations (CDMOs), biotech firms, and research institutions are further expanding market adoption.

Increasing prevalence of chronic diseases, cancer, and rare disorders is fueling demand for advanced biologics, thereby boosting the use of sophisticated bioprocessing equipment. Regulatory emphasis on quality, safety, and compliance is encouraging manufacturers to invest in state-of-the-art process technologies. Emerging markets with expanding biopharmaceutical infrastructure are witnessing higher adoption of scalable and cost-effective bioprocessing systems. Integration with digital platforms, real-time monitoring, and AI-driven analytics is enhancing process control, yield optimization, and risk management. With their ability to support efficient, high-quality, and reproducible biologic production, bioprocessing equipment is becoming a cornerstone of modern pharmaceutical manufacturing.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bioprocessing-equipment-market?sp

Bioprocessing Equipment Market: Major Players

Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation (Cytiva), Merck KGaA, Eppendorf, Bionet, Solaris Biotech, PBS Biotech, Inc., Applikon Biotechnology (Getinge / Applikon), Celartia and among others.

Segment Covered in the Bioprocessing Equipment Market:

➥ By Product Type: Bioreactors, Filtration Systems, Chromatography Systems, Cell Culture Systems, Mixing Systems, Control & Monitoring Systems, Others

➥ By Process: Upstream Processing, Downstream Processing

➥ By Application: Vaccines, Gene & Cell Therapy, Monoclonal Antibodies (mAbs), Recombinant Proteins, Others

➥ By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Academic & Research Institutes

Research Process:

Both primary and secondary data sources have been used in the Bioprocessing Equipment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Bioprocessing Equipment Market Research Industry:

➠ Who leads the Bioprocessing Equipment industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Bioprocessing Equipment market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Bioprocessing Equipment market growth?
➠ What are the dominant sales and distribution strategies in the Bioprocessing Equipment industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=bioprocessing-equipment-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.